Clinical trials recruiting in Whangarei, New Zealand
7
Recruiting trials
15
Conditions
Phase breakdown
Phase 3 5Not applicable 2
Conditions recruiting in Whangarei, New Zealand
Recruiting trials in Whangarei, New Zealand
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
- EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)
- The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
- Zimmer Biomet Shoulder Arthroplasty PMCF
Common questions
How many clinical trials are recruiting in Whangarei, New Zealand?
7 recruiting trials have at least one study site in Whangarei, New Zealand.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.